(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Inmunología experimental > DA - CIMA - Terapia génica y Hepatología - Inmunología experimental - Artículos de revista >

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr
Autor(es) : Sarobe, P. (Pablo)
Lasarte, J.J. (Juan José)
Golvano, J.J. (José Javier)
Prieto, I. (Isidro)
Gullon, A. (Arturo)
Soto, M.J. (María José)
Labarga, P. (Pablo)
Prieto, J. (Jesús)
Borras-Cuesta, F. (Francisco)
Palabras clave : Gene Products, vpr/immunology
HIV Antibodies/biosynthesis
HIV-1/immunology
Immunodominant Epitopes/immunology
T-Lymphocytes, Helper-Inducer/immunology
Fecha incorporación: 1994
Editorial : Raven Press
Versión del editor: http://journals.lww.com/jaids/Abstract/1994/07000/Induction_of_Neutralizing_Antibodies_Against_Human.1.aspx
ISSN: 0894-9255
Cita: Sarobe P, Lasarte JJ, Golvano JJ, Prieto I, Gullon A, Soto MJ, et al. Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr. J Acquir Immune Defic Syndr 1994 Jul;7(7):635-640.
Resumen
Identification of immunodominant T-helper-cell determinants after natural infection is an important step in the design of immunogens for potential use in vaccination. Using cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals and a panel of peptides encompassing the sequence of the regulatory protein vpr from HIV-1, we identified the T-helper determinant QLLFIHFRIGCRHSR, which is active in 37.5% of these individuals. To gain insight on the efficacy of this peptide in helping induce neutralizing antibodies against a B-cell determinant (BD), we synthesized constructs containing B- and T-cell determinants and tested them in BALB/c mice, the highest responders to the T-cell determinant moiety among several strains tested. These immunogens induced antibodies against two chosen B-cell determinants from HIV-1IIIB gp160 (amino acids 310-322 from the V3 loop of gp120 and 736-751 from gp41) that were able to neutralize HIV-1 infection in vitro. The highest neutralization titer against HIV-1IIIB was obtained by immunization with the homopolymer of the construct containing the T-cell epitope from vpr and the B-cell epitope from the V3 loop. We believe that the immunodominant T-cell determinant from vpr is a promising epitope to consider in the design of future peptide vaccines.
Enlace permanente: http://hdl.handle.net/10171/21678
Aparece en las colecciones: DA - Medicina - Medicina Interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología experimental - Artículos de revista

Ficheros en este registro:

No hay ficheros asociados a este ítem.

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.